Tan EY, Danpanichkul P, Yong JN, Yu Z, Tan DJH, Lim WH, et al. Liver cancer in 2021: global burden of disease study. J Hepatol. 2025;82(5):851–60.

Article  PubMed  Google Scholar 

Zhang J, Hu C, Xie X, Qi L, Li C, Li S. Immune checkpoint inhibitors in HBV-caused hepatocellular carcinoma therapy. Vaccines. 2023. https://doi.org/10.3390/vaccines11030614.

Article  PubMed  PubMed Central  Google Scholar 

Wu Y, Zeng Z, Chen S, Zhou D, Tong G, Du D. Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review. Front Immunol. 2025;16:1531249.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang W, Hong X, Xiao Y, Wang H, Zeng X. Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer. 2025;1880(3):189310.

Article  CAS  PubMed  Google Scholar 

Marin JJG, Macias RIR, Monte MJ, Romero MR, Asensio M, Sanchez-Martin A, et al. Molecular bases of drug resistance in hepatocellular carcinoma. Cancers (Basel). 2020. https://doi.org/10.3390/cancers12061663.

Article  PubMed  PubMed Central  Google Scholar 

Krupa K, Fudalej M, Cencelewicz-Lesikow A, Badowska-Kozakiewicz A, Czerw A, Deptala A. Current treatment methods in hepatocellular carcinoma. Cancers (Basel). 2024;16(23):4059.

Article  CAS  PubMed  Google Scholar 

Sankar K, Gong J, Osipov A, Miles SA, Kosari K, Nissen NN, et al. Recent advances in the management of hepatocellular carcinoma. Clin Mol Hepatol. 2024;30(1):1–15.

Article  PubMed  Google Scholar 

Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.

Article  PubMed  PubMed Central  Google Scholar 

Kong F, You H, Kong D, Zheng K, Tang R. The interaction of hepatitis B virus with the ubiquitin proteasome system in viral replication and associated pathogenesis. Virol J. 2019;16(1):73.

Article  PubMed  PubMed Central  Google Scholar 

You H, Qin S, Zhang F, Hu W, Li X, Liu D, et al. Regulation of pattern-recognition receptor signaling by HBX during Hepatitis B virus infection. Front Immunol. 2022;13:829923.

Article  CAS  PubMed  PubMed Central  Google Scholar 

You H, Wang X, Ma L, Zhang F, Zhang H, Wang Y, et al. Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Commun Signal. 2023;21(1):70.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z, et al. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence. 2024;15(1):2421231.

Article  PubMed  PubMed Central  Google Scholar 

Kong F, Bao E, Zhong Y, Wang Y, Liu R, Zhang H, et al. HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression. Hepatol Commun. 2025;9(5):e0680.

PubMed  PubMed Central  Google Scholar 

You HJ, Ma LH, Wang X, Wang YX, Zhang HY, Bao ES, et al. Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis. Cell Oncol (Dordr). 2024;47(2):639–55.

Article  CAS  PubMed  Google Scholar 

You H, Zhang N, Yu T, Ma L, Li Q, Wang X, et al. Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis. Br J Cancer. 2023;128(6):992–1004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

You H, Yuan D, Li Q, Zhang N, Kong D, Yu T, et al. Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis. Int J Biol Macromol. 2023;226:996–1009.

Article  CAS  PubMed  Google Scholar 

Ahluwalia S, Ahmad B, Salim U, Ghosh D, Kamuju V, Ghosh A, et al. Hepatitis B virus-encoded HBsAg contributes to hepatocarcinogenesis by inducing the oncogenic long noncoding RNA LINC00665 through the NF-kappaB pathway. Microbiol Spectr. 2022;10(5):e0273121.

Article  PubMed  Google Scholar 

Naidu S, Margeridon S. Chronic hepatitis B virus persistence: mechanisms and insights. Cureus. 2025;17(2):e78944.

PubMed  PubMed Central  Google Scholar 

Feld JJ, Lok AS, Zoulim F. New perspectives on development of curative strategies for chronic hepatitis B. Clin Gastroenterol Hepatol. 2023;21(8):2040–50.

Article  CAS  PubMed  Google Scholar 

Birnbaum F, Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol. 1990;64(7):3319–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Georgi C, D’Souza S, Osiowy C, Coffin CS, Cooper CL. Chronic hepatitis B virus persistence: mechanisms, consequences and implications for achieving cure. Ann Hepatol. 2025;30(2):101938.

Article  PubMed  Google Scholar 

Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397–408.

Article  PubMed  Google Scholar 

Cheng ST, Hu JL, Ren JH, Yu HB, Zhong S, Wai Wong VK, et al. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx. J Hepatol. 2021;74(3):522–34.

Article  CAS  PubMed  Google Scholar 

Liu W, Zhang X, Deng Y, Wang D, Li H. Unfolding HBx for an epigenetic switch of HBV cccDNA minichromosome. Protein Cell. 2025;0(0):0.

Google Scholar 

Xue Y, Wang MJ, Yang ZT, Yu DM, Han Y, Huang D, et al. Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant. Emerg Microbes Infect. 2017;6(3):e15.

CAS  PubMed  PubMed Central  Google Scholar 

Li S, Zhao K, Liu S, Wu C, Yao Y, Cao L, et al. HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance. Virus Res. 2015;210:119–25.

Article  CAS  PubMed  Google Scholar 

Ma H, Yan QZ, Ma JR, Li DF, Yang JL. Overview of the immunological mechanisms in hepatitis B virus reactivation: implications for disease progression and management strategies. World J Gastroenterol. 2024;30(10):1295–312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medina C, García AH, Crespo FI, Toro FI, Mayora SJ, De Sanctis JB. A synopsis of Hepatitis C virus treatments and future perspectives. Curr Issues Mol Biol. 2023;45(10):8255–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Sun Y, Song X, Wang Z, Zhang Y, Zhao Y, et al. Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes. Cell Mol Immunol. 2021;18(8):1871–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisicaro P, Barili V, Rossi M, Montali I, Vecchi A, Acerbi G, et al. Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches. Front Immunol. 2020;11:849.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Pasquale C, Campana S, Barberi C, Sidoti Migliore G, Oliveri D, Lanza M, et al. Human hepatitis B virus negatively impacts the protective immune crosstalk between natural killer and dendritic cells. Hepatology. 2021;74(2):550–65.

Article